Argenx
ARGX
#534
Rank
C$54.80 B
Marketcap
$896.30
Share price
-0.35%
Change (1 day)
90.53%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$0.76 Billion

According to Argenx 's latest financial reports the company's total liabilities are C$0.76 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Argenx - Total liabilities on balance sheet (from 2021 to 2020)

Total liabilities by year

Year Total liabilities Change
2022-12-31C$0.43 B7.99%
2021-12-31C$0.40 B-57.57%
2020-12-31C$0.94 B50.97%
2019-12-31C$0.62 B780.53%
2018-12-31C$71.41 M51.91%
2017-12-31C$47.01 M-25.41%
2016-12-31C$63.02 M337.69%
2015-12-31C$14.4 M-0.44%
2014-12-31C$14.46 M115.4%
2013-12-31C$6.71 M-18.68%
2012-12-31C$8.25 M54.64%
2011-12-31C$5.34 M97.96%
2010-12-31C$2.69 M